ADD/ADHD News

The release of the 2011 AAP practice guidelines for attention-deficit/hyperactivity disorder was associated with an end to an increasing trend in diagnosis of preschoolers, according to data recently published in Pediatrics. Rates of prescribing stimulants remained steady.

Clinicians should be cautious when assessing test results of children with autism who are evaluated for attention-deficit/hyperactivity symptoms because screening tools do not appropriately distinguish those symptoms with symptoms associated with autism spectrum disorder, according to recently published study findings.

Recent findings identified significant inheritable structural and functional connectivity features associated with ADHD and indicated that shared genetic factors may contribute to phenotypic associations between functional and structural connections.

Persistence of ADHD symptoms across childhood and adolescence was associated with polygenic risk scores for ADHD, according to recent findings.

Dasotraline, a dopamine and norepinephrine reuptake inhibitor, improved ADHD symptoms in children aged 6 to 12 years, according to study findings announced by Sunovion Pharmaceuticals.

SAN ANTONIO — Poster data presented here indicated efficacy and safety of Dyanavel XR, an extended-release oral suspension amphetamine for attention-deficit/hyperactivity disorder in children aged 6 years and older.

SAN FRANCISCO — When considering medication for children and adolescents with ADHD, depression and anxiety, PCPs should start with a low dose of a long-acting drug, and then gradually increase as needed, according to data presented at the 2016 AAP National Conference & Exhibition.

SAN FRANCISCO — Despite receiving stable doses of stimulant medications, children and adolescents with attention-deficit/hyperactivity disorder displayed inadequate symptom control and functional impairment related to the condition during their early morning routine before school, according to survey results presented at the 2016 AAP National Conference and Exhibition.

SAN ANTONIO — In this video, Timothy Wilens, PhD, chief of the division of child and adolescent psychiatry and co-director of the Center for Addiction Medicine at Massachusetts General Hospital, provides an update on ADHD medications.

Analysis of national data indicated adverse childhood experiences were more common among children with ADHD than those without the developmental disorder.